From the aforementioned, it is proposed that PLC activation is an early response to α1-AR activation by norepinephrine and that subsequent signal transduction events that augment PLC gene expression and activities may constitute a sequence of cyclical events designed to perpetuate cardiac hypertrophy and facilitate its ultimate transition into heart failure (Figure 2). Here, HSPG2 is linked to cardiac hypertrophy.